Ginkgo Bioworks Holdings, Inc.

General ticker "DNA" information:

  • Sector: Materials
  • Industry: Chemicals
  • Capitalization: $640.7M (TTM average)

Ginkgo Bioworks Holdings, Inc. does not follow the US Stock Market performance with the rate: -6.5%.

Estimated limits based on current volatility of 5.0%: low 7.13$, high 7.89$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.39$, 13.56$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.53$, 17.30$]

Financial Metrics affecting the DNA estimates:

  • Negative: Non-GAAP EPS, $ of -9.30 <= 0.04
  • Positive: 43.26 < Shareholder equity ratio, % of 51.98 <= 63.75
  • Negative: Operating cash flow per share per price, % of -38.81 <= 1.79
  • Negative: negative Net income
  • Negative: negative Operating income
  • Positive: 5.40 < Industry operating profit margin (median), % of 5.91
  • Positive: Industry inventory ratio change (median), % of -0.44 <= -0.28
  • Negative: Industry earnings per price (median), % of 3.41 <= 3.66

Similar symbols

Short-term DNA quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-0955.566.577.588.5
Price $

Long-term DNA plot with estimates

020406080100Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−3−2−10
DNAS&P500MaterialsNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $477.71MM $251.46MM $227.04MM
Operating Expenses $2,686.66MM $1,115.86MM $786.80MM
Operating Income $-2,208.95MM $-864.41MM $-559.76MM
Non-Operating Income $87.55MM $-28.53MM $12.25MM
Interest Expense $0.11MM $0.09MM $0.09MM
R&D Expense $1,052.64MM $580.62MM $424.06MM
Income(Loss) $-2,121.40MM $-892.94MM $-547.51MM
Taxes $-15.03MM $-0.07MM $-0.48MM
Profit(Loss)* $-2,104.93MM $-892.87MM $-547.03MM
Stockholders Equity $1,736.28MM $1,097.15MM $716.06MM
Inventory $4.36MM $0.05MM $0.00MM
Assets $2,539.32MM $1,665.34MM $1,377.45MM
Operating Cash Flow $-252.20MM $-295.50MM $-319.58MM
Capital expenditure $52.27MM $40.80MM $62.54MM
Investing Cash Flow $-67.39MM $-80.69MM $-62.24MM
Financing Cash Flow $95.34MM $-3.22MM $-1.74MM
Earnings Per Share** $-50.20 $-18.40 $-10.54

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.